(Q38151902)

29 August 2017

Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies? (English)

1 reference

29 August 2017

Clara Dees

1

1 reference

PubMed ID

24118232

29 August 2017

Jörg H W Distler

series ordinal

2

1 reference

29 August 2017

1 November 2013

1 reference

29 August 2017

Experimental Dermatology

1 reference

29 August 2017

22

1 reference

29 August 2017

11

1 reference

29 August 2017

710-713

1 reference

29 August 2017

1 reference

Changes in causes of death in systemic sclerosis, 1972-2002

21 January 2018

1 reference

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

21 January 2018

1 reference

Systemic sclerosis: a prototypic multisystem fibrotic disorder

21 January 2018

1 reference

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

21 January 2018

1 reference

Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis

21 January 2018

1 reference

Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.

21 January 2018

1 reference

Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis.

21 January 2018

1 reference

Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?

21 January 2018

1 reference

21 January 2018

1 reference

Alternative wnt signaling is initiated by distinct receptors.

21 January 2018

1 reference

A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling

21 January 2018

1 reference

The Wnt signaling pathway in development and disease

21 January 2018

1 reference

Towards an integrated view of Wnt signaling in development

21 January 2018

1 reference

21 January 2018

1 reference

Wnt/β-catenin signaling and disease

21 January 2018

1 reference

Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density

21 January 2018

1 reference

DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation

21 January 2018

1 reference

PARsing the phrase "all in for Axin"- Wnt pathway targets in cancer

21 January 2018

1 reference

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

21 January 2018

1 reference

The many faces and functions of β-catenin

21 January 2018

1 reference

Wnt/beta-catenin signaling promotes renal interstitial fibrosis

21 January 2018

1 reference

Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction

21 January 2018

1 reference

Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation

21 January 2018

1 reference

Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids

21 January 2018

1 reference

Axin pathway activity regulates in vivo pY654-β-catenin accumulation and pulmonary fibrosis

21 January 2018

1 reference

Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells

21 January 2018

1 reference

Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis

21 January 2018

1 reference

β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis

21 January 2018

1 reference

Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.

21 January 2018

1 reference

Sustained β-catenin activity in dermal fibroblasts is sufficient for skin fibrosis

21 January 2018

1 reference

Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling

21 January 2018

1 reference

Drugging Wnt signalling in cancer

21 January 2018

1 reference

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

21 January 2018

1 reference

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

21 January 2018

1 reference

Review: recent clinical trials in epigenetic therapy

21 January 2018

1 reference

Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EXD.12255

1 reference

29 August 2017

1 reference

PubMed ID

24118232